Virus Filtration Market Overview
The virus filtration market size is estimated to reach $6.5 billion by 2026 and is poised to grow at a CAGR of 10.8% over the forecast period of 2021-2026. Virus filtration systems generally use a membrane barrier that stops or retains the main viral particle. The polymeric membrane stops the virus on the surface and within the pores of the membrane. Virus filtration has always been considered a robust and effective technology in the biotechnology space, and now its shift is focusing on home-based appliances. The advent of nanofiltration technology has further expanded the scope of viral inactivation. The former has pores ranging between 1-10 nanometers and are just smaller than the primer technologies of microfiltration and ultrafiltration. Chromatography is yet another important aspect of separating the viral particles, as it helps in differentiating the viral particles from the protein and DNA contaminants. Additionally, they use the concept of reversible interaction between the viral capsid and the biological ligand by using the chromatography matrix. The increasing expenditure on R&D activities by multinationals along with the rising cases of chronic and infectious diseases are some of the recognized factors driving the virus filtration industry forward in the projected period of 2021-2026.
Virus Filtration Market Segmentation Analysis – By Product
The virus filtration market based on the product can be further segmented into Filtration Systems; Kits, Reagents, & Consumables, and Services. The Kits, Reagents & consumables segment held a dominant market share in the year 2020. It is owing to their increased usage in virus filtration. Moreover, the focus in the last year was predominantly focused on making vaccines and therapeutics owing to the advent of Covid-19. The vaccines developed heavily rely on the antigens of the main virus, which in turn allows the body to allow protection. Hence, it is involved in the upstream processes as well. It depends on the type of substrate, quality criteria, control strategy yield, and technology options available. Egg-based vaccines, viral vector vaccines, and DNA vaccines all follow the process of virus filtration. For example, companies like Pfizer received $1.95 billion from the US government in the year 2020 to develop and research a vaccine for Covid-19, steps such as these are propelling the growth.
However, the filtration systems segment is estimated to be the fastest-growing, with a CAGR of 11.4% over the forecast period of 2021-2026. It is owing to the advent of personalized medicines that cure specific ailments such as cancer. Cancer is now regarded as the second most common reason for death globally. Additionally, people are opting for medications and therapeutics which now have propelled the marketers to follow the filtration systems as it helps in achieving economies of scale and does not hinder the quality of the product.
Request for Sample Report @ https://www.industryarc.com/pdfdownload.php?id=16737
Report Price: $ 4500 (Single User License)
Virus Filtration Market Segmentation Analysis – By End Users
The virus filtration market based on the end-users can be further segmented into Pharmaceutical and Biotechnology, Contract Research Organization, Academia &Research, Research Laboratories, and others. The pharmaceutical and biotechnology segment held a dominant market share in the year 2020. It is owing to the ready budgetary allocation for developing new drugs and medicines, which has resulted in increased R&D spending. As per reports, in 2019, the pharmaceutical industry spent $83 billion on R&D, which is ten times more than what was spent in 1980, which overtly reflects in the spending the virus filtration market.
However, contract research organizations are estimated to be the fastest-growing, with a CAGR of 11.7% over the forecast period of 2021-2026. It is owing to various factors such as, and it helps the big pharmaceutical companies to reduce the total expenditure. As the burden for hiring new research staff and investing in house R&D can mitigate huge amounts of profits. The companies are now trying to achieve low risk-high profit module by transferring works such as immunogenicity, biomarkers, and pharmacokinetics practices to CROs. Additionally, they can handle increasingly complex drugs and clinical trials and overtly reduce the time to market.
Virus Filtration Market Segmentation Analysis – By Geography
The virus filtration market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America’s virus filtration market held a dominant market size of 36% as compared to the other regions. It is owing to the predominant position of the region, especially the US to follow automation in healthcare processes. Additionally, the filtration systems automation has allowed the various ancillaries to support its growth, as the following region has some renowned players. Lastly, the region’s focus from the last year has been to create robust infrastructure, which will not allow any new outbreaks, that have the potential to create a new pandemic.
The Asia Pacific offers lucrative growth opportunities to marketers in the projected period of 2021-2026. It is owing to the rising FDI from the biotechnology companies in the regions such as India and China. The countries offer economies of scale and the favorable trade policies are further propelling the virus filtration market to grow at a substantial pace. Additionally, owing to the rising pollutants in the majority of the countries in this region, air purification has been a trending topic and area of innovation that has allowed for the growth of virus filtration.
Virus Filtration Market Drivers
Virus Filters add a key line of defense against potential pathogens which is driving the market growth
The virus retentive filters are extensively used by the manufacturers in the process streams. More so, the biotechnology and pharmaceutical companies use the following filter or the process to avoid the introduction of certain pathogens in the important and niche classes of medicines. Specialty high-flow virus filters are now available against the traditional filters, which allows stopping the viruses via the media supplements into the cell cultures. Moreover, after the advent of coronavirus, the companies in the sector modulated their technologies to catch the following pathogen. The coronavirus particle typically ranges from 100-160 nanometres, and even the small droplets of the Sars virus can be potentially stopped from entering the cell cultures with the use of technology such as DFF. Lastly, HEPA filters are now overtly used across industries owing to the potential to filter out disease-causing viruses.
An increase in the cases of chronic illnesses across the globe has propelled the marketers to develop advanced class drugs which have allowed the use of virus filtration as the base technology
It is evident that the global disease burden in terms of chronic illness has been increasing. As per WHO, one in every six deaths worldwide is caused due to cancer. Moreover, diabetes prevalence has quadrupled in the last four decades, and the numbers globally are close to 550 million. Additionally, chronic illnesses don’t come alone but bring along various other ailments such as kidney failure, eye-ailments, and lastly heart attacks. The major drug manufacturer globally is readily researching possible drugs and vaccines which could prevent the disease, or help in reducing the severity of the disease. The advent of new drugs requires the manufacturers to follow virus filtration techniques in the downstream processes, which are now allowing for the growth of the market.
Direct Purchase @ https://www.industryarc.com/purchasereport.php?id=16737
Virus Filtration Market Challenges
The continuous processing within the virus filter might not perform as per expectation and can lead to failed batches of products, which is hindering the market growth
The virus filtration is a crucial downstream process, additionally, virus filtration can be in terms of batch filtration and continuous flow filtration. In cases of the continuous virus filtration process, the batch systems are closed and more complex, hence the variability in the protein concentration, the irregularity of pH values, and conductivity pose a challenge to the virus filter. Moreover, the filters are also challenged when the minimum titer was 106 pfu/ml. Additionally, companies need to spend extra amounts of money to run parallel filtration which will allow in-line testing during the continuous phase of batch filtration.
Virus Filtration Market Competitive Landscape
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Virus Filtration Market. The top 10- Virus Filtration Market companies include:
Merck KgaA
Thermo Fisher Scientific Inc
Charles River Laboratories International Inc
GE Healthcare
Lonza Group Ltd
Wuxi Pharma Tech
Danaher Corporation
Asahi Kasei Medical Co. Ltd
Pall Corporation
Sartorius
Recent Developments
In August 2021, Honeywell announced their “drop-in” coronavirus filter. The following would be in a form of coating which will be capable of clearing out 97% of the Sars-Cov-19 virus. Moreover, the product launch is especially for the schools and government offices that have heating and cooling operations in place and don’t wish to spend heavily on denser filtration.
In February 2021, Estonian UV tech has released the first virus-killing air purifier. The device is worn around the neck which has the power to filter 99% of viruses and bacteria. The device has shown protection against E.Coli 99.88% protection and also against Alphavirus, which it claims to stop 99.44%. The process goes through the internal filter and a germicidal UV-C light, then it is ventilated to the user.
Key Takeaways
Geographically, North America’s virus filtration market held a dominant market share in the year 2020. It is owing to the presence of robust medical infrastructure companies and the budgetary allocation to control virus leakages and maintain standard bio-hazard standards. However, Asia-Pacific is set to grow at a lucrative pace owing to the recent developments in the field of research and multinationals setting up CROs in different regions to save costs.
The increase in the expenditure pertaining to the development of robust vaccines, along with the adoption of single-use technologies have acted as a driver for the market. However, stringent regulations levied by the regulatory authorities are a grave market challenge.
A detailed analysis of the strengths, weaknesses, opportunities, and threats will be provided in the Virus Filtration Market report.
Relevant Titles
Consumer Water and Air Treatment Market
https://www.industryarc.com/Report/10617/consumer-water-air-treatment-market.html
For more Lifesciences and Healthcare Market reports, please click here
About IndustryARC: IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to sales@industryarc.com to discuss more about our consulting services.
Media Contact
Company Name: IndustryARC
Contact Person: Mr. Venkat Reddy
Email: Send Email
Phone: (+1) 970-236-3677
Address:Madhapur
City: Hyderabad
Country: India
Website: https://www.industryarc.com/